Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)

Turkey · Delayed Price · Currency is TRY

99.70

+4.05 (4.23%)

At close: Oct 6, 2026

IST:ONCSM Financials Overview

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	734.91	709.08	490.18	347.24	292.94	127.99
Revenue Growth	3.23%	44.66%	41.16%	18.54%	128.88%	-
Gross Profit	427.58	319.83	181.31	51.67	100.71	88.34
Operating Income	233.63	152.66	7.02	-86.11	33.01	70.37
Net Income	70.64	50.39	-77.45	-115.23	-20.76	71.73
Earnings Per Share	2.96	2.11	-3.25	-4.83	-1.71	303.08
EPS Growth	524.34%	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Unallocated	-	-	1.35	4.72	7.45	3.36
Turkey	927.27	829.6	477.3	323.79	258.09	92.94
Overseas	-	-	11.53	18.73	27.4	31.68
Eliminations	-	-120.52	-	-	-	-
Total	734.91	709.08	490.18	347.24	292.94	127.99

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	30.1	45.38	58.46	84.53	19.25	5.77
Total Debt	178.05	86.83	61.01	90.05	23.2	14.32
Net Cash (Debt)	-147.95	-41.45	-2.55	-5.52	-3.95	-8.55
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.20	-1.74	-0.11	-0.23	-0.33	-36.11

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	98.31	69.36	112.12	-36.92	52.69	51.73
Capital Expenditures	-76.34	-60.92	-28.55	-45.58	-26.02	-10.96
Free Cash Flow	21.97	8.44	83.57	-82.5	26.67	40.76
Free Cash Flow Growth	-74.99%	-89.90%	-	-	-34.58%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.18%	45.11%	36.99%	14.88%	34.38%	69.02%
Operating Margin	31.79%	21.53%	1.43%	-24.80%	11.27%	54.98%
Pretax Margin	16.84%	10.35%	-13.57%	-39.22%	-0.85%	62.83%
Profit Margin	9.61%	7.11%	-15.80%	-33.18%	-7.09%	56.05%
FCF Margin	2.99%	1.19%	17.05%	-23.76%	9.10%	31.85%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.415	-	-	-	0.415
Dividend Per Share Growth	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	32.30	124.47	-	-	-	-
P/FCF Ratio	103.85	743.43	30.28	-	-	-
PS Ratio	3.10	8.85	5.16	10.28	-	-